ADAR1 Capital Management’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YF
SL
ADAR1 Capital Management's WHWK Position: Q3 2026 in Review
ADAR1 Capital Management held its Whitehawk Therapeutics (WHWK) position steady in Q3 2026 at 1,341,394 shares worth $5.04M. The position accounts for 0.21% of the portfolio, ranked #103.
ADAR1 Capital Management first reported a position in WHWK in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.14M in Q2 2026. 91 funds tracked by Wall St. Rank hold WHWK as of Q3 2026.
- ADAR1 Capital Management held 1,341,394 shares of Whitehawk Therapeutics worth $5.04M as of Q3 2026.
- ADAR1 Capital Management left its Whitehawk Therapeutics share count unchanged in Q3 2026.
- Whitehawk Therapeutics made up 0.21% of ADAR1 Capital Management's portfolio in Q3 2026, its #103 holding.
- ADAR1 Capital Management first reported a position in Whitehawk Therapeutics in Q4 2025 and has held it in 4 quarters since.
- ADAR1 Capital Management's Whitehawk Therapeutics position peaked at $6.14M in Q2 2026.
- 91 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2026.
Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.